Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:866-875
Published online before print February 4, 2008, doi: 10.1161/CIRCULATIONAHA.107.752220
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
117/7/866    most recent
CIRCULATIONAHA.107.752220v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hassel, D.
Right arrow Articles by Rottbauer, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hassel, D.
Right arrow Articles by Rottbauer, W.
Related Collections
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrowRelated Article

(Circulation. 2008;117:866-875.)
© 2008 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Deficient Zebrafish Ether-à-Go-Go–Related Gene Channel Gating Causes Short-QT Syndrome in Zebrafish Reggae Mutants

David Hassel, MS*; Eberhard P. Scholz, MD*; Nicole Trano, MS*; Oliver Friedrich, PhD; Steffen Just, PhD; Benjamin Meder, MD; Daniel L. Weiss, PhD; Edgar Zitron, MD; Sabine Marquart, MS; Britta Vogel, MD; Christoph A. Karle, MD; Gunnar Seemann, PhD; Mark C. Fishman, MD; Hugo A. Katus, MD; Wolfgang Rottbauer, MD

From the Department of Internal Medicine III (D.H., E.P.S., N.T., S.J., B.M., E.Z., S.M., B.V., C.A.K., H.A.K., W.R.), University Hospital Heidelberg, Heidelberg, Germany; Department of Physiology and Pathophysiology (O.F.), University of Heidelberg, Heidelberg, Germany; Institute of Biomedical Engineering (D.L.W., G.S.), University of Karlsruhe, Karlsruhe, Germany; and Cardiovascular Research Center (M.C.F.), Massachusetts General Hospital and Department of Medicine, Harvard Medical School, Boston, Mass.

Correspondence to Wolfgang Rottbauer, Department of Internal Medicine III, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. E-mail wolfgang.rottbauer{at}med.uni-heidelberg.de

Received May 23, 2007; accepted December 7, 2007.

Background— Genetic predisposition is believed to be responsible for most clinically significant arrhythmias; however, suitable genetic animal models to study disease mechanisms and evaluate new treatment strategies are largely lacking.

Methods and Results— In search of suitable arrhythmia models, we isolated the zebrafish mutation reggae (reg), which displays clinical features of the malignant human short-QT syndrome such as accelerated cardiac repolarization accompanied by cardiac fibrillation. By positional cloning, we identified the reg mutation that resides within the voltage sensor of the zebrafish ether-à-go-go–related gene (zERG) potassium channel. The mutation causes premature zERG channel activation and defective inactivation, which results in shortened action potential duration and accelerated cardiac repolarization. Genetic and pharmacological inhibition of zERG rescues recessive reg mutant embryos, which confirms the gain-of-function effect of the reg mutation on zERG channel function in vivo. Accordingly, QT intervals in ECGs from heterozygous and homozygous reg mutant adult zebrafish are considerably shorter than in wild-type zebrafish.

Conclusions— With its molecular and pathophysiological concordance to the human arrhythmia syndrome, zebrafish reg represents the first animal model for human short-QT syndrome.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 857-859. [Full Text]